Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Europe Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product (Reagents & Kits and Instruments), By Sample (Fecal, Saliva, Skin, and Others), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030

Published Date : 01-Apr-2024

Pages: 143

Formats: PDF

The Europe Microbiome Diagnostics Market would witness market growth of 17.0% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Microbiome Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $24,425.8 Thousands by 2030. The UK market is showcasing a CAGR of 16% during (2023 - 2030). Additionally, The France market would register a CAGR of 17.9% during (2023 - 2030).

Europe Microbiome Diagnostics Market

It is crucial in understanding the link between the gut microbiome and metabolic disorders such as obesity, type 2 diabetes, and metabolic syndrome. Research has shown that gut microbiota composition and function alterations can influence host metabolism, energy balance, and insulin sensitivity. It can identify microbial biomarkers associated with metabolic dysfunction, providing insights into disease mechanisms and potential therapeutic targets.

Likewise, the microbiome plays a central role in modulating immune function and responses. It studies how the gut microbiome interacts with the immune system and influences immune-mediated diseases such as allergies, autoimmune disorders, and inflammatory conditions. By profiling the microbiome-immune axis, it can identify microbial signatures associated with immune dysregulation and inflammatory diseases, informing therapeutic interventions and immune-modulating strategies. Also, the skin microbiome has emerged as a key player in maintaining skin health and integrity. It is utilized to study the composition and diversity of microbial communities on the skin and their role in dermatological conditions such as acne, eczema, psoriasis, and wound healing. Understanding the skin microbiome’s dynamics and its interaction with the host can inform personalized skincare interventions and therapeutic approaches for various dermatological ailments.

In addition, the high prevalence of respiratory diseases in Europe drives demand for microbiome diagnostics in research and clinical settings. According to Eurostat, respiratory illnesses accounted for 347 867 deaths in the EU in 2020 or 6.7% of all fatalities among citizens. In 2020, the proportion of deaths from respiratory diseases in Malta, Denmark, and Ireland was considerably higher than the EU average, at 10.5 %, 10.4 %, and 10.0 %, respectively. As research continues to unravel the complex interplay between the respiratory microbiome and respiratory health, it will play an increasingly critical role in shaping the future of respiratory medicine in Europe and beyond. Thus, the high prevalence of respiratory diseases and the expansion of the pharmaceutical industry in the region is propelling the market’s growth.

Free Valuable Insights: The Global Microbiome Diagnostics Market will Hit USD 416.1 Million by 2030, at a CAGR of 17.5%

Based on Application, the market is segmented into Disease Diagnostics (Gastrointestinal Disorders, Metabolic Diseases and Others) and Research Application. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Sample, the market is segmented into Fecal, Saliva, Skin, and Others. Based on Technology, the market is segmented into 16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics and Others. Based on End User, the market is segmented into Hospitals, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Illumina, Inc.
  • Becton, Dickinson and Company
  • Genetic Analysis AS
  • Microba Life Sciences Limited
  • BioMe Oxford Ltd 
  • Viome Life Sciences, Inc.
  • GoodGut S.L.U. (HIPRA, S.A.)
  • Sun Genomics
  • Origin Sciences Limited
  • Decode Age

Europe Microbiome Diagnostics Market Report Segmentation

By Application

  • Disease Diagnostics
    • Gastrointestinal Disorders
    • Metabolic Diseases
    • Others
  • Research Application

By Product

  • Reagents & Kits
  • Instruments

By Sample

  • Fecal
  • Saliva
  • Skin
  • Others

By Technology

  • 16S rRNA Sequencing
  • Shot Gun Metagenomics
  • Metatranscriptomics
  • Others

By End User

  • Hospitals
  • Academic & Research Institutes
  • Biotechnology & Pharmaceutical Companies

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Microbiome Diagnostics Market, by Application
1.4.2 Europe Microbiome Diagnostics Market, by Product
1.4.3 Europe Microbiome Diagnostics Market, by Sample
1.4.4 Europe Microbiome Diagnostics Market, by Technology
1.4.5 Europe Microbiome Diagnostics Market, by End User
1.4.6 Europe Microbiome Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Microbiome Diagnostics Market
Chapter 5. Europe Microbiome Diagnostics Market by Application

5.1 Europe Disease Diagnostics Market by Country
5.2 Europe Microbiome Diagnostics Market by Disease Diagnostics Type
5.2.1 Europe Gastrointestinal Disorders Market by Country
5.2.2 Europe Metabolic Diseases Market by Country
5.2.3 Europe Others Market by Country
5.3 Europe Research Application Market by Country

Chapter 6. Europe Microbiome Diagnostics Market by Product
6.1 Europe Reagents & Kits Market by Country
6.2 Europe Instruments Market by Country

Chapter 7. Europe Microbiome Diagnostics Market by Sample
7.1 Europe Fecal Market by Country
7.2 Europe Saliva Market by Country
7.3 Europe Skin Market by Country
7.4 Europe Others Market by Country

Chapter 8. Europe Microbiome Diagnostics Market by Technology
8.1 Europe 16S rRNA Sequencing Market by Country
8.2 Europe Shot Gun Metagenomics Market by Country
8.3 Europe Metatranscriptomics Market by Country
8.4 Europe Others Market by Country

Chapter 9. Europe Microbiome Diagnostics Market by End User
9.1 Europe Hospitals Market by Country
9.2 Europe Academic & Research Institutes Market by Country
9.3 Europe Biotechnology & Pharmaceutical Companies Market by Country

Chapter 10. Europe Microbiome Diagnostics Market by Country
10.1 Germany Microbiome Diagnostics Market
10.1.1 Germany Microbiome Diagnostics Market by Application
10.1.1.1 Germany Microbiome Diagnostics Market by Disease Diagnostics Type
10.1.2 Germany Microbiome Diagnostics Market by Product
10.1.3 Germany Microbiome Diagnostics Market by Sample
10.1.4 Germany Microbiome Diagnostics Market by Technology
10.1.5 Germany Microbiome Diagnostics Market by End User
10.2 UK Microbiome Diagnostics Market
10.2.1 UK Microbiome Diagnostics Market by Application
10.2.1.1 UK Microbiome Diagnostics Market by Disease Diagnostics Type
10.2.2 UK Microbiome Diagnostics Market by Product
10.2.3 UK Microbiome Diagnostics Market by Sample
10.2.4 UK Microbiome Diagnostics Market by Technology
10.2.5 UK Microbiome Diagnostics Market by End User
10.3 France Microbiome Diagnostics Market
10.3.1 France Microbiome Diagnostics Market by Application
10.3.1.1 France Microbiome Diagnostics Market by Disease Diagnostics Type
10.3.2 France Microbiome Diagnostics Market by Product
10.3.3 France Microbiome Diagnostics Market by Sample
10.3.4 France Microbiome Diagnostics Market by Technology
10.3.5 France Microbiome Diagnostics Market by End User
10.4 Russia Microbiome Diagnostics Market
10.4.1 Russia Microbiome Diagnostics Market by Application
10.4.1.1 Russia Microbiome Diagnostics Market by Disease Diagnostics Type
10.4.2 Russia Microbiome Diagnostics Market by Product
10.4.3 Russia Microbiome Diagnostics Market by Sample
10.4.4 Russia Microbiome Diagnostics Market by Technology
10.4.5 Russia Microbiome Diagnostics Market by End User
10.5 Spain Microbiome Diagnostics Market
10.5.1 Spain Microbiome Diagnostics Market by Application
10.5.1.1 Spain Microbiome Diagnostics Market by Disease Diagnostics Type
10.5.2 Spain Microbiome Diagnostics Market by Product
10.5.3 Spain Microbiome Diagnostics Market by Sample
10.5.4 Spain Microbiome Diagnostics Market by Technology
10.5.5 Spain Microbiome Diagnostics Market by End User
10.6 Italy Microbiome Diagnostics Market
10.6.1 Italy Microbiome Diagnostics Market by Application
10.6.1.1 Italy Microbiome Diagnostics Market by Disease Diagnostics Type
10.6.2 Italy Microbiome Diagnostics Market by Product
10.6.3 Italy Microbiome Diagnostics Market by Sample
10.6.4 Italy Microbiome Diagnostics Market by Technology
10.6.5 Italy Microbiome Diagnostics Market by End User
10.7 Rest of Europe Microbiome Diagnostics Market
10.7.1 Rest of Europe Microbiome Diagnostics Market by Application
10.7.1.1 Rest of Europe Microbiome Diagnostics Market by Disease Diagnostics Type
10.7.2 Rest of Europe Microbiome Diagnostics Market by Product
10.7.3 Rest of Europe Microbiome Diagnostics Market by Sample
10.7.4 Rest of Europe Microbiome Diagnostics Market by Technology
10.7.5 Rest of Europe Microbiome Diagnostics Market by End User

Chapter 11. Company Profiles
11.1 Illumina, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expense
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.6 SWOT Analysis
11.2 Becton, Dickinson, and Company
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Product Launches and Product Expansions:
11.2.5.2 Trails and Approvals:
11.2.6 SWOT Analysis
11.3 Genetic Analysis AS
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional Analysis
11.3.4 Recent strategies and developments:
11.3.4.1 Partnerships, Collaborations, and Agreements:
11.4 Microba Life Sciences Limited
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Partnerships, Collaborations, and Agreements:
11.4.5.2 Product Launches and Product Expansions:
11.5 BioMe Oxford Ltd
11.5.1 Company Overview
11.5.2 Recent strategies and developments:
11.5.2.1 Partnerships, Collaborations, and Agreements:
11.6 Viome Life Sciences, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Product Launches and Product Expansions:
11.6.2.2 Acquisition and Mergers:
11.7 GoodGut S.L.U. (HIPRA, S.A.)
11.7.1 Company Overview
11.8 Sun Genomics
11.8.1 Company Overview
11.9 Origin Sciences Limited
11.9.1 Company Overview
11.10. Decode Age
11.10.1 Company Overview
TABLE 1 Europe Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 2 Europe Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 3 Europe Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 4 Europe Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 5 Europe Disease Diagnostics Market by Country, 2019 - 2022, USD Thousands
TABLE 6 Europe Disease Diagnostics Market by Country, 2023 - 2030, USD Thousands
TABLE 7 Europe Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 8 Europe Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 9 Europe Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Thousands
TABLE 10 Europe Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Thousands
TABLE 11 Europe Metabolic Diseases Market by Country, 2019 - 2022, USD Thousands
TABLE 12 Europe Metabolic Diseases Market by Country, 2023 - 2030, USD Thousands
TABLE 13 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 14 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 15 Europe Research Application Market by Country, 2019 - 2022, USD Thousands
TABLE 16 Europe Research Application Market by Country, 2023 - 2030, USD Thousands
TABLE 17 Europe Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 18 Europe Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 19 Europe Reagents & Kits Market by Country, 2019 - 2022, USD Thousands
TABLE 20 Europe Reagents & Kits Market by Country, 2023 - 2030, USD Thousands
TABLE 21 Europe Instruments Market by Country, 2019 - 2022, USD Thousands
TABLE 22 Europe Instruments Market by Country, 2023 - 2030, USD Thousands
TABLE 23 Europe Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 24 Europe Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 25 Europe Fecal Market by Country, 2019 - 2022, USD Thousands
TABLE 26 Europe Fecal Market by Country, 2023 - 2030, USD Thousands
TABLE 27 Europe Saliva Market by Country, 2019 - 2022, USD Thousands
TABLE 28 Europe Saliva Market by Country, 2023 - 2030, USD Thousands
TABLE 29 Europe Skin Market by Country, 2019 - 2022, USD Thousands
TABLE 30 Europe Skin Market by Country, 2023 - 2030, USD Thousands
TABLE 31 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 32 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 33 Europe Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 34 Europe Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 35 Europe 16S rRNA Sequencing Market by Country, 2019 - 2022, USD Thousands
TABLE 36 Europe 16S rRNA Sequencing Market by Country, 2023 - 2030, USD Thousands
TABLE 37 Europe Shot Gun Metagenomics Market by Country, 2019 - 2022, USD Thousands
TABLE 38 Europe Shot Gun Metagenomics Market by Country, 2023 - 2030, USD Thousands
TABLE 39 Europe Metatranscriptomics Market by Country, 2019 - 2022, USD Thousands
TABLE 40 Europe Metatranscriptomics Market by Country, 2023 - 2030, USD Thousands
TABLE 41 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 42 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 43 Europe Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 44 Europe Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 45 Europe Hospitals Market by Country, 2019 - 2022, USD Thousands
TABLE 46 Europe Hospitals Market by Country, 2023 - 2030, USD Thousands
TABLE 47 Europe Academic & Research Institutes Market by Country, 2019 - 2022, USD Thousands
TABLE 48 Europe Academic & Research Institutes Market by Country, 2023 - 2030, USD Thousands
TABLE 49 Europe Biotechnology & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Thousands
TABLE 50 Europe Biotechnology & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Thousands
TABLE 51 Europe Microbiome Diagnostics Market by Country, 2019 - 2022, USD Thousands
TABLE 52 Europe Microbiome Diagnostics Market by Country, 2023 - 2030, USD Thousands
TABLE 53 Germany Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 54 Germany Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 55 Germany Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 56 Germany Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 57 Germany Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 58 Germany Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 59 Germany Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 60 Germany Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 61 Germany Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 62 Germany Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 63 Germany Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 64 Germany Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 65 Germany Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 66 Germany Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 67 UK Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 68 UK Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 69 UK Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 70 UK Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 71 UK Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 72 UK Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 73 UK Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 74 UK Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 75 UK Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 76 UK Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 77 UK Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 78 UK Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 79 UK Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 80 UK Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 81 France Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 82 France Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 83 France Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 84 France Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 85 France Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 86 France Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 87 France Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 88 France Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 89 France Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 90 France Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 91 France Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 92 France Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 93 France Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 94 France Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 95 Russia Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 96 Russia Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 97 Russia Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 98 Russia Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 99 Russia Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 100 Russia Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 101 Russia Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 102 Russia Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 103 Russia Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 104 Russia Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 105 Russia Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 106 Russia Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 107 Russia Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 108 Russia Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 109 Spain Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 110 Spain Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 111 Spain Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 112 Spain Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 113 Spain Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 114 Spain Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 115 Spain Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 116 Spain Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 117 Spain Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 118 Spain Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 119 Spain Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 120 Spain Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 121 Spain Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 122 Spain Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 123 Italy Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 124 Italy Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 125 Italy Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 126 Italy Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 127 Italy Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 128 Italy Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 129 Italy Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 130 Italy Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 131 Italy Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 132 Italy Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 133 Italy Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 134 Italy Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 135 Italy Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 136 Italy Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 137 Rest of Europe Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 138 Rest of Europe Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 139 Rest of Europe Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 140 Rest of Europe Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 141 Rest of Europe Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 142 Rest of Europe Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 143 Rest of Europe Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 144 Rest of Europe Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 145 Rest of Europe Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 146 Rest of Europe Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 147 Rest of Europe Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 148 Rest of Europe Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 149 Rest of Europe Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 150 Rest of Europe Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 151 key information – Illumina, Inc.
TABLE 152 Key Information – Becton, Dickinson and Company
TABLE 153 Key Information – Genetic Analysis AS
TABLE 154 Key Information – Microba Life Sciences Limited
TABLE 155 Key Information –BioMe Oxford Ltd
TABLE 156 Key Information – Viome Life Sciences, Inc.
TABLE 157 Key Information – GoodGut S.L.U.
TABLE 158 Key Information – Sun Genomics
TABLE 159 Key Information – Origin Sciences Limited
TABLE 160 Key Information – Decode Age

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Microbiome Diagnostics Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Microbiome Diagnostics Market
FIG 4 Porter’s Five Forces Analysis – Microbiome Diagnostics Market
FIG 5 Europe Microbiome Diagnostics Market share by Application, 2022
FIG 6 Europe Microbiome Diagnostics Market share by Application, 2030
FIG 7 Europe Microbiome Diagnostics Market by Application, 2019 - 2030, USD Thousands
FIG 8 Europe Microbiome Diagnostics Market share by Product, 2022
FIG 9 Europe Microbiome Diagnostics Market share by Product, 2030
FIG 10 Europe Microbiome Diagnostics Market by Product, 2019 - 2030, USD Thousands
FIG 11 Europe Microbiome Diagnostics Market by Sample, 2022
FIG 12 Europe Microbiome Diagnostics Market by Sample, 2030
FIG 13 Europe Microbiome Diagnostics Market by Sample, 2019 - 2030, USD Thousands
FIG 14 Europe Microbiome Diagnostics Market share by Technology, 2022
FIG 15 Europe Microbiome Diagnostics Market share by Technology, 2030
FIG 16 Europe Microbiome Diagnostics Market by Technology, 2019 - 2030, USD Thousands
FIG 17 Europe Microbiome Diagnostics Market share by End User, 2022
FIG 18 Europe Microbiome Diagnostics Market share by End User, 2030
FIG 19 Europe Microbiome Diagnostics Market by End User, 2019 - 2030, USD Thousands
FIG 20 Europe Microbiome Diagnostics Market share by Country, 2022
FIG 21 Europe Microbiome Diagnostics Market share by Country, 2030
FIG 22 Europe Microbiome Diagnostics Market by Country, 2019 - 2030, USD Thousands
FIG 23 Swot Analysis: Illumina, Inc.
FIG 24 Recent strategies and developments: Becton, Dickinson, and Company
FIG 25 SWOT Analysis: Becton, Dickinson and company
FIG 26 Recent strategies and developments: Microba Life Sciences
FIG 27 Recent strategies and developments: Viome Life Sciences

Purchase Full Report of
Europe Microbiome Diagnostics Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL